$AMS

American Shared Hospital Q2 2026 Earnings Call Transcript - American Shared Hospital (AMEX:AMS)

American Shared Hospital Services (AMEX:AMS) held its Q2 2026 earnings call. The company reported Q2 revenue of about $8.4 million, up 19% year over year, and first-half revenue up 18% to over $15.5 million. It cited higher patient volumes, Proton Beam activity, and international operations. First-half operating cash was $4.4 million and cash rose over 80% to $6.8 million, despite a $909,000 credit-loss charge.

Original reporting
Published Aug 13, 2026, 5:39 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 5:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
American Shared Hospital Q2 2026 Earnings Call Transcript - American Shared Hospital (AMEX:AMS) — source image
Decision brief

The 30-second read

$AMSBullishMed
01

Why it matters

Traders can reassess near-term liquidity and operating momentum using reported revenue growth, cash generation, and the updated capital-structure framework with Fifth Third Bank, while monitoring credit-loss trends and execution of new center plans.

02

Market read

Fresh earnings and liquidity details plus a new bank forbearance framework can move valuation expectations, but credit-loss and financing execution remain key swing factors.

03

What to watch

Investors may underweight the $909k Rhode Island receivables credit-loss charge and the execution risk of new center development (Rhode Island) and international expansion timelines.

Relevance 8/10Novelty 7/10Timing: earnings call transcript published after Q2 results release (today)

Background

The transcript covers American Shared Hospital Services Q2 2026 results and strategy shift from equipment leasing toward a diversified radiation oncology platform, including Proton Beam and Gamma Knife operations.

Company-level read

Ticker impact

$AMSBullishMedium confidence
Context

American Shared Hospital reported Q2 2026 revenue of about $8.4M (+19% YoY) and $4.4M first-half operating cash, plus a Fifth Third forbearance amendment.

Expected impact

Near-term bias modestly positive if investors focus on cash build and utilization gains, but credit-loss and financing overhang can cap upside.

Evidence & confidence

Revenue growth, utilization improvements, and cash balance increase are concrete positives, while the $909k Rhode Island credit-loss charge and ongoing capital-structure negotiations are key risks. The transcript is a primary earnings disclosure, but guidance details are not fully visible in the provided excerpt.

Market effects

Highlights demand and reimbursement sensitivity in radiation oncology and the importance of utilization for profitability, which can influence sentiment toward similar providers.

Rhode Island center expansion plans and receivables credit-loss experience may affect perceived credit quality for regional healthcare operators.

International treatment center performance (Peru Gamma Knife, Latin America expansion) reinforces that cross-border operations can diversify growth drivers.

Counterpoint

Cash generation and revenue growth may not fully offset credit risk and financing dependence, especially with ongoing bank forbearance and subordinated capital.

Key entities

  • American Shared Hospital Services

    Subject of the earnings call transcript, reporting Q2 2026 financial and operational updates and capital-structure actions.

  • Fifth Third Bank

    Entered into a Third Amendment and Forbearance Agreement with the company, providing a defined financing framework.

  • Alexis Wallace

    Promoted to interim CFO from Chief Accounting Officer; prior CFO Scott Freck moved on.

Related articles

$AMSMed

American Shared Hospital Services Q2 Net Loss Widens to $514,000 Despite Revenue Growth – Minichart

American Shared Hospital Services (NYSE American: AMS) reported a Q2 2026 net loss of $514,000, or $0.07 per diluted share, widening from a $280,000 loss a year earlier, despite revenue rising 19.2% to $8.43 million. Direct patient services drove growth, while gross profit and operating loss worsened. Cash rose to $6.511 million at June 30, 2026, and the company later arranged financing with Fifth Third Bank.

$AMSMed

American Shared Hospital Services (AMS) (Q2 2026) Earnings Call Highlights: Strong

American Shared Hospital Services (AMS) reported Q2 2026 earnings call highlights including 19% year-over-year revenue growth driven by direct patient services, higher international Gamma Knife volumes, and improving proton beam performance. Proton beam revenue rose 22% to about $2.3M in the quarter and $4.3M for six months. Reported results were impacted by $285k legal costs and a $909k credit-loss allowance. Cash equivalents and restricted cash were about $6.8M.

$AMSHighAI 8/10

American Shared Hospital (NYSE: AMS) grows revenue while warning on going concern

American Shared Hospital Services (NYSE: AMS) reported Q2 2026 revenue of $8.43M and $15.51M for the first half, up from $7.07M and $13.18M a year earlier, driven by direct patient services and higher PBRT and Gamma Knife volumes. The company posted net losses of $0.51M in Q2 and $1.13M for six months and disclosed substantial doubt about its going concern due to covenant breaches and debt default notices.

$AMSMedAI 8/10

Earnings call transcript: American Shared Hospital Services posts Q2 2026 revenue beat

American Shared Hospital Services reported Q2 2026 revenue of $8.4 million, up 19.2% year over year and above the $7.56 million forecast. Adjusted EPS was a loss of $0.07 versus an expected loss of $0.02. Direct patient services rose to $4.9 million and proton beam revenue to about $2.3 million. Cash and equivalents were $6.8 million; management discussed refinancing debt due in 2027.

$AMSMed

American Shared Hospital Q2 Results: Revenue up 19% to $8.4 million

American Shared Hospital Services (AMEX: AMS) reported Q2 2026 revenue of $8.4 million, up 19% year over year. Direct patient services rose about 40% to $4.9 million, while Proton Beam Radiation Therapy revenue increased 22% to about $2.3 million. Adjusted EBITDA fell to about $1.3 million from $1.7 million. Cash increased to $6.8 million by quarter end.

$AMSMed

AMERICAN SHARED HOSPITAL SERVICES (AMS): Results of Operations and Financial Condition

AMERICAN SHARED HOSPITAL SERVICES (AMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_1004185.htm EXHIBIT 99.1 ex_1004185.htm Exhibit 99.1 American Shared Hospital Services Reports Second Quarter and First Half 2026 Financial Results Second Quarter Revenue Increased 19% to $8.4 Million Driven by Strong Growth from Direct Patient Services Operating Cas